Opus Point Partners Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.1M | Buy |
|
|||||
|
2019
Q2 | $969K | Hold |
|
|||||
|
2019
Q1 | $1.25M | Sell |
|
|||||
|
2018
Q4 | $1.04M | Buy |
|
|||||
|
2018
Q3 | $1.18M | Sell |
|
|||||
|
2018
Q2 | $1.39M | Buy |
|
|||||
|
2018
Q1 | $1.63M | Sell |
|
|||||
|
2017
Q4 | $5.47M | Sell |
|
|||||
|
2017
Q3 | $5.58M | Sell |
|
|||||
|
2017
Q2 | $3.92M | Sell |
|
|||||
|
2017
Q1 | $4.62M | Buy |
|
|||||
|
2016
Q4 | $3.32M | Buy |
|
|||||
|
2016
Q3 | $3.05M | Buy |
|
|||||
|
2016
Q2 | $2.42M | Sell |
|
|||||
|
2016
Q1 | $4.87M | Buy |
|
|||||
|
2015
Q4 | $4.73M | Buy |
|
|||||
|
2015
Q3 | $3.89M | Buy |
|
|||||
|
2015
Q2 | $4.19M | Sell |
|
|||||
|
2015
Q1 | $3.9M | Buy |
|
|||||
|
2014
Q4 | $1.73M | Buy |
|